GlassScriptPhysician profile
Morgan Stover
NPI 1104522366
$4,140.96
in general payments reported to CMS, 2019-2025
32 companies · $1,829 in 2025
The $1,829 reported for 2025 was more than what 90% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,011 · 2024: $1,301 · 2025: $1,829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,140.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $497.76 | 2023-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $387.29 | 2023-2025 | Verquvo, Winrevair |
| Novo Nordisk INC | $338.28 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $316.02 | 2023-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $302.42 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $262.32 | 2024-2025 | |
| Pfizer INC. | $247.59 | 2023-2025 | |
| Amgen INC. | $240.98 | 2023-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $187.85 | 2023-2025 | Lifevest |
| Boston Scientific Corporation | $166.01 | 2023-2025 | Watchman Flx, Watchman Access System, Watchman |
| Alnylam Pharmaceuticals INC. | $141.73 | 2024-2025 | Onpattro |
| Esperion Therapeutics, INC. | $111.09 | 2023-2025 | Nexletol |
| Medtronic, INC. | $99.04 | 2025 | Aurora Ev-Icd Mri Surescan, Concertotm |
| Astrazeneca Pharmaceuticals LP | $98.44 | 2023-2025 | Andexxa, Farxiga |
| Vital Connect, INC | $90.84 | 2024-2025 | Vitalpatch Rtm |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $75.65 | 2025 | Attruby |
| Lexicon Pharmaceuticals, INC. | $71.00 | 2023-2024 | Inpefa |
| Abiomed | $60.85 | 2024-2025 | Impella |
| Inspire Medical Systems, INC. | $53.29 | 2024 | Inspire |
| Biotronik INC. | $47.74 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $47.56 | 2023 | Arcalyst |
| Lilly USA, LLC | $47.22 | 2025 | Zepbound |
| Cardiva Medical, INC. | $35.39 | 2025 | Optowire |
| Janssen Pharmaceuticals, INC | $35.14 | 2023 | Xarelto |
| Analog Devices INC. | $33.80 | 2024 | Sensinel Cpm Wearable |
| Kestra Medical Technology Services, INC. | $28.14 | 2024 | Assure Wcd |
| Chiesi USA, INC. | $27.42 | 2025 | Kengreal, Cleviprex |
| Xeris Pharmaceuticals, INC. | $23.02 | 2025 | Keveyis |
| Sanofi-Aventis U.S. LLC | $22.45 | 2023 | |
| Impulse Dynamics (USA) INC. | $16.25 | 2025 | Optimizer |
| Baxter Healthcare | $14.57 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Kowa Pharmaceuticals America, INC. | $13.81 | 2023 | Livalo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Stover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.